Heteroaryl imidazolone derivatives as JAK inhibitors

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

Saved in:
Bibliographic Details
Main Authors GOMEZ CASTILLO, ELENA, EASTWOOD, PAUL ROBERT, GONZALEZ RODRIGUEZ, JACOB, BACH TANA, JORDI
Format Patent
LanguageChinese
English
Published 16.01.2012
Subjects
Online AccessGet full text

Cover

Loading…